During Phase 1 the contractors will perform research to:
1. elaborate the solution design and determine the approach to be taken to develop the new solutions and:
2. demonstrate the technical, financial and commercial feasibility of the proposed concepts and approach to meet the procurement need.
Phase 1 Awards:
Budget of awarded contracts: 642.399,78 EUR
Tender received: 7
Number of contracts awarded: 4
Selected tenders:
– HUFIAT CANCER LIQUIDATION
– Lead: Euformatics Oy
– Consortium members: Euformatics Oy, Oncompas Medicine, ViennaLab Diagnostics
– KU LEUVEN
– AGILENT TECHNOLOGIES BELGIUM
– ONCODNA
Duration : 4 months (31st January to 30th May 2023)